Table 4.

Characteristics of patients with biologic treatment

Patient ID	Gender	Age (years)	Body mass index kg/m2	Current smoker (Yes/No)	Refined Hurley stage	Biologic regimen	Started before/after surgery	Number of treatment weeks before surgery	Treatment ongoing at end of study? (week 26)	Relapse (Yes/No)
6	F	51	36.7	No*	III	Adalimumab 40 mg QW	Before	14	Yes	No
9	F	34	28.7	No*	IIB	Adalimumab 40 mg QW	Before	13	Yes	No
24	M	26	33.0	Yes†	III	Infliximab 500mg E6W	Before	184§	Yes	No
28	F	44	25.7	Yes	IIB	Adalimumab 40 mg QW	Before	221	Yes	No
39	F	50	32.2	No‡	III	Adalimumab 40 mg QW	After	−7¶	Yes	No

^*Former smoker.

^†Smokes fruit tobacco.

^‡Never smoked.

^§Estimation: no exact start date was reported.

^¶Biologic treatment started 7 weeks after surgery.